Inveltys™ (loteprednol etabonate) – New drug approval
August 23, 2018 - Kala Pharmaceuticals announced the FDA approval of Inveltys (loteprednol etabonate) 1% ophthalmic suspension, for the treatment of post-operative inflammation and pain following ocular surgery.
Download PDF
